|
Mounting public concern about contamination in products ranging from peanuts to pet food has led to a proposal to split the FDA into two agencies — one to oversee food, and another to monitor drug safety. An increasing number of pharmaceutical executives see that setup as a way to accelerate drug approvals. Many consumer advocates also believe that the proposal will shine a brighter spotlight on food processing, which they argue has been neglected by regulators. Does an overhaul of FDA make sense — or does it needlessly increase the federal bureaucracy?
The preceding article is a "sneak peek" from Quality Control, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Quality Control today.
|
Users who posted comments:
bwire (1), denicemCRQA06 (1), Guest (1), RTFVerterra (1)